Desialylation of platelets by pneumococcal neuraminidase A induces ADP-dependent platelet hyper-reactivity

TY - JOUR

T1 - Desialylation of platelets by pneumococcal neuraminidase A induces ADP-dependent platelet hyper-reactivity

AU - Kullaya, Vesla

AU - de Jonge, Marien I

AU - Langereis, Jeroen D

AU - van der Gaast-de Jongh, Christa E

AU - Büll, Christian

AU - Adema, Gosse J

AU - Lefeber, Dirk

AU - Cremers, Amelieke J

AU - Mmbaga, Blandina T

AU - de Groot, Phillip G

AU - de Mast, Quirijn

AU - van der Ven, Andre J

N1 - Copyright © 2018 American Society for Microbiology.

PY - 2018/10

Y1 - 2018/10

N2 - Platelets are increasingly recognized to play a role in the complications of Streptococcus pneumoniae infections. S. pneumoniae expresses neuraminidases, which may alter glycans on the platelet surface. In the present study, we investigated the capability of pneumococcal neuraminidase A (NanA) to remove sialic acid (desialylation) from the platelet surface, the consequences for the platelet activation status and reactivity, and the ability of neuraminidase inhibitors to prevent these effects. Our results show that soluble NanA induces platelet desialylation. Whereas desialylation itself did not induce platelet activation (P-selectin expression and platelet fibrinogen binding), platelets became hyper-reactive to ex vivo stimulation by adenosine diphosphate (ADP) and crosslinked collagen-related peptide (CRP-XL). Platelet aggregation with leukocytes also increased. These processes were dependent on the ADP-pathway as inhibitors of this pathway (apyrase and ticagrelor) abrogated platelet hyper-reactivity. Inhibition of NanA-induced platelet desialylation by neuraminidase inhibitors (e.g. oseltamivir acid) also prevented the platelet effects of NanA. Collectively, our findings show that soluble NanA can desialylate platelets leading to platelet hyper-reactivity which can be prevented by neuraminidase inhibitors.

AB - Platelets are increasingly recognized to play a role in the complications of Streptococcus pneumoniae infections. S. pneumoniae expresses neuraminidases, which may alter glycans on the platelet surface. In the present study, we investigated the capability of pneumococcal neuraminidase A (NanA) to remove sialic acid (desialylation) from the platelet surface, the consequences for the platelet activation status and reactivity, and the ability of neuraminidase inhibitors to prevent these effects. Our results show that soluble NanA induces platelet desialylation. Whereas desialylation itself did not induce platelet activation (P-selectin expression and platelet fibrinogen binding), platelets became hyper-reactive to ex vivo stimulation by adenosine diphosphate (ADP) and crosslinked collagen-related peptide (CRP-XL). Platelet aggregation with leukocytes also increased. These processes were dependent on the ADP-pathway as inhibitors of this pathway (apyrase and ticagrelor) abrogated platelet hyper-reactivity. Inhibition of NanA-induced platelet desialylation by neuraminidase inhibitors (e.g. oseltamivir acid) also prevented the platelet effects of NanA. Collectively, our findings show that soluble NanA can desialylate platelets leading to platelet hyper-reactivity which can be prevented by neuraminidase inhibitors.

KW - Desialylation

KW - Nana

KW - Platelets

KW - Sialic acid

KW - Streptococcus pneumoniae

KW - NanA

KW - sialic acid

KW - desialylation

KW - platelets

U2 - 10.1128/iai.00213-18

DO - 10.1128/iai.00213-18

M3 - Journal article

C2 - 30037798

SN - 0019-9567

VL - 86

JO - Infection and Immunity

JF - Infection and Immunity

IS - 10

M1 - e00213-18

ER -